Medical imaging in the diagnosis and management of cancer pain

Current Pain and Headache Reports

Volumn 13, Issue 4, 2009, Pages 261-270

  Cuevas, Carlos ^a   Shibata, Dean ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE; GADOLINIUM; IODINATED CONTRAST MEDIUM; PHENOL; TECHNETIUM 99M;

ANAPHYLAXIS; BACKACHE; BONE METASTASIS; BONE PAIN; BONE SCINTISCANNING; CANCER PAIN; CELIAC PLEXUS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CRYOTHERAPY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; HUMAN; IMAGE QUALITY; IMAGE RECONSTRUCTION; MICROBUBBLE; MYELOGRAPHY; NEPHROGENIC SYSTEMIC FIBROSIS; NERVE BLOCK; NEURILEMOMA; NEUROFIBROMA; NEUROGRAPHY; NEUROPATHIC PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; RADIOFREQUENCY ABLATION; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINAL CORD COMPRESSION; SPINAL CORD METASTASIS; SPINAL CORD TUMOR;

CONTRAST MEDIA; DISEASE MANAGEMENT; HUMANS; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; NEOPLASMS; PAIN; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67651160785     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-009-0042-9     Document Type: Review

References (44)

1. Boone J: MulOidetector CT: opportunities, challenges, and concerns associated with scanners with 64 or more detector rows. Radiology 2006, 241: 334-337.
2. Johnson T, Krauß B, Sedlmair M, et al.: Material differentiation by dual energy CT: Initial experience. Eur Radiol 2007, 17: 1510-1517.
3. Donnino R, Jacobs J, Doshi J, et al.: Dual-source versus single-source cardiac CT angiography: Comparison of diagnostic image quality. AJR Am J Roentgenol 2009, 192: 1051-1056.
4. GE Healthcare: Solving the high image quality with low radiation dose paradox. Available at http://www.gehealthcare.com/usen/ct/products/docs/ radiation_dose_paradox09.pdf. Accessed May 2009.
5. US Food and Drug Administration: Information for healthcare professionals micro-bubble contrast agents (marketed as Definity (perflutren lipid microsphere) injectable suspension and Optison (perflutren protein-type A microspheres for injection). Available at http://www.fda.gov/CDER/drug/InfoSheets/HCP/microbubbleHCP.htm. Accessed May 2009.
6. Greenberger PA, Patterson R: The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol 1991, 87: 867-872.
7. Lasser EC, Berry CC, Mishkin MM, et al.: Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media. AJR Am J Roentgenol 1994, 162: 523-526.
8. Wertman R, Altun E, Martin D, et al.: Risk of nephrogenic systemic fibrosis: Evaluation of gadolinium chelate contrast. Radiology 2008, 248: 799-806.
9. Ohno Y, Koyama H, Onishi Y, et al.: Non-small cell lung cancer: whole-body MR examination for M-stage assessment: Utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 2008, 248: 643-654.
10. Nakamoto Y, Osman M, Wahl RL: Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG. Clin Nucl Med 2003, 28: 302-307.
11. Song Y, Kang W, Jang S, et al.: Comparison of F-18 FDG PET and Tc-99m MDP bone scan according to metastatic sites in detecting bone metastasis from non-small cell lung cancer. J Nucl Med 2007, 48: 358P.
12. O HJ, Yoo I, Choi W, et al.: Comparison of FDG PET/CT and Tc-99m HDP bone scan in the detection of bone metastases in stomach cancer patients. J Nucl Med 2007, 48: 383P.
13. Langsteger W, Heinisch M, Fogelman I: The role of fluoro-deoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med 2006, 36: 73-92.
14. Even-Sapir E, Metser U, Flusser G, et al.: Assessment of malignant skeletal disease: Initial experience with 18Ffluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med 2004, 45: 272-278.
15. Even-Sapir E, Metser U, Mishani E, et al.: The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med 2006, 47: 287-297.
16. Kostas JP, Dailiana Z, Xenakis T, et al.: Back pain caused by benign tumors and tumor-like lesions of the thoracolumbar spine. Am J Orthop 2001, 30: 50-56.
17. Chamberlain MC: Comparative spine imaging in leptomeningeal metastases. J Neurooncol 1995, 23: 233-238.
18. Husband DJ, Grant KA, Romaniuk CS: MRI in the diagnosis and treatment of suspected malignant spinal cord compression. Br J Radiol 2001, 74: 15-23.
19. Hagenau C, Grosh W, Currie M, Wiley RG: Comparison of spinal magnetic resonance imaging and myelography in cancer patients. J Clin Oncol 1987, 5: 1663-1669.
20. Sandow BA, Donnal JF: Myelography complications and current practice patterns. AJR Am J Roentgenol 2005, 185: 768-771.
21. Tartaglino LM, Flanders AE, Vinitski S, Friedman DP: Metallic artifacts on MR images of the postoperative spine: Reduction with fast spin-echo techniques. Radiology 1994, 190: 565-569.
22. Aagaard BD, Maravilla KR, Kliot M: MR neurography. MR imaging of peripheral nerves. Magn Reson Imaging Clin N Am 1998, 6: 179-194.
23. Binder DK, Smith JS, Barbaro NM: Primary brachial plexus tumors: imaging, surgical, and pathological findings in 25 patients. Neurosurg Focus 2004, 16: E11.
24. Ganju A, Roosen N, Kline DG, Tiel RL: Outcomes in a consecutive series of 111 surgically treated plexal tumors: A review of the experience at the Louisiana State University Health Sciences Center. J Neurosurg 2001, 95: 51-60.
25. Lusk MD, Kline DG, Garcia CA: Tumors of the brachial plexus. Neurosurgery 1987, 21: 439-453.
26. Lingawi SS, Bilbey JH, Munk PL, et al.: MR imaging of brachial plexopathy in breast cancer patients without palpable recurrence. Skeletal Radiol 1999, 28: 318-323.
27. Qayyum A, MacVicar AD, Padhani AR, et al.: Symptomatic brachial plexopathy following treatment for breast cancer: Utility of MR imaging with surface-coil techniques. Radiology 2000, 214: 837-842.
28. Zhou L, Yousem DM, Chaudhry V: Role of magnetic resonance neurography in brachial plexus lesions. Muscle Nerve 2004, 30: 305-309.
29. Takahara T, Hendrikse J, Yamashita T, et al.: Diffusion-weighted MR neurography of the brachial plexus: Feasibility study. Radiology 2008, 249: 653-660.
30. Evans BA, Stevens JC, Dyck PJ: Lumbosacral plexus neuropathy. Neurology 1981, 31: 1327-1330.
31. Gangi A, Dietemann JL, Schultz A, et al.: Interventional radiologic procedures with CT guidance in cancer pain management. Radiographics 1996, 16: 1289-1304.
32. Gofeld M: Ultrasonography inApain medicine: a critical review. Pain Pract 2008, 8: 226-240.
33. Goetz MP, Callstrom MR, Charboneau JW, et al.: Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: A multicenter study. J Clin Oncol 2004, 22: 300-306.
34. Nakatsuka A, Yamakado K, Maeda M, et al.: Radiofrequency ablation combined with bone cement injection for the treatment of bone malignancies. J Vasc Interv Radiol 2004, 15: 707-712.
35. Gronemeyer DH, Schirp S, Gevargez A: Image-guided radiofrequency ablation of spinal tumors: Preliminary experience with an expandable array electrode. Cancer J 2002, 8: 33-39.
36. Mercadante S, NAcosia F: Celiac plexus block: a reappraisal. Reg Anesth Pain Med 1998, 23: 37-48.
37. Eisenberg E, Carr DB, Chalmers TC: Neurolytic celiac plexus block for treatment of cancer pain: A meta-analysis. Anesth Analg 1995, 80: 290-295.
38. Lillemoe KD, Cameron JL, Kaufman HS, et al.: Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg 1993, 217: 447-455.
39. Gunaratnam NT, Sarma AV, Norton ID, et al.: A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest Endosc 2001, 54: 316-324.
40. Brodano GB, Cappuccio M, Gasbarrini A, et al.: Vertebroplasty in the treatment of vertebral metastases: Clinical cases and review of the literature. Eur Rev Med Pharmacol Sci 2007, 11: 91-100.
41. Kaemmerlen P, Thiesse P, Bouvard H, et al.: Percutaneous vertebroplasty in the treatment of metastases. Technic and results [in French]. J Radiol 1989, 70: 557-562.
42. Calmels V, Vallee JN, Rose M, Chiras J: Osteoblastic and mixed spinal metastases: Evaluation of the analgesic efficacy of percutaneous vertebroplasty. AJNR Am J Neuroradiol 2007, 28: 570-574.
43. Barragan-Campos HM, Vallee JN, Lo D, et al.: Percutaneous vertebroplasty for spinal metastases: Complications. Radiology 2006, 238: 354-362.
44. Antila H, Kirvela O: Neurolytic thoracic paravertebral block in cancer pain. A clinical report. Acta Anaesthesiol Scand 1998, 42: 581-585.